New Formulary Guidance Could Help Broaden Coverage of Key Drugs

Drug Industry Daily
KEYWORDS Guidances / Medicare
A A

Analysts and democratic staffers are pointing to U.S. Pharmacopeia’s (USP) recent decision to revise its model formulary guidelines as an opportunity to ensure that beneficiaries have access to the broadest array of certain essential drugs under the new prescription drug plan.

To View This Article:

Login

Subscribe To Drug Industry Daily